Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Draper is a U.S.-based nonprofit research, development, and manufacturing company best known for advanced engineering in defense, space, and biotechnology systems. In healthcare and life sciences, it develops microphysiological system platforms for disease modeling and drug development, bioprocessing technologies for cellular therapies, diagnostics and biosecurity tools, and therapeutic medical devices. Its flagship health-related platform is the PREDICT96 tissue chip system, which is used to model human physiology, disease, and drug responses, including immune-cell recirculation and infectious disease applications. Draper is also advancing the LEAP pediatric heart valve, a growth-adaptive heart valve that has shown preclinical feasibility for infants and young children. The organization primarily operates as a nonprofit applied R&D and technology commercialization partner rather than a traditional therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Draper.